CERS6 and lung cancer: Taken together with results in prior studies, our findings are consistent with the idea that miR‐101 has an onco‐suppressive function and also suggest activity of the miR‐101‐ CERS6 pathway contributes to lung cancer pathogenesis (Figure 6).